TL;DR
- Cronos (CRO) jumped nearly 16% after its inclusion in Truth Social’s Crypto Blue-Chip ETF was confirmed, with a 5% allocation.
- The native token of the blockchain created by Crypto.com climbed from under $0.082 to almost $0.094, driven by its unexpectedly strong weight within the fund.
- The ETF, still pending SEC approval, will allocate 70% to Bitcoin and stands out for including five assets in a market without authorized multi-crypto funds.
Cronos (CRO) surged over 15% after it was confirmed as part of the Crypto Blue-Chip ETF that Truth Social filed with the SEC.
The native token of the blockchain developed by Crypto.com went from trading below $0.082 to nearly $0.094. The market reacted immediately to the weight it will carry within the fund, which will allocate 5% of its capital to CRO — a higher share than many expected compared to other, larger-cap cryptocurrencies.
The ETF was proposed by Truth Social in partnership with Trump Media & Technology Group. Its goal is to bring together top cryptocurrencies into a single financial product to be listed on NYSE Arca. The fund’s distribution was set at 70% for Bitcoin, 15% for Ethereum, 8% for Solana, 5% for Cronos, and 2% for XRP. Although Bitcoin maintains the largest allocation, its price barely moved after the news broke. BTC bounced back from levels below $108,000 but failed to reclaim the $109,600 reached the previous day.
Cronos Was the Only Asset That Moved the Market
Ethereum and XRP posted modest gains of just over 1% in the last 24 hours, while Solana stayed flat, barely holding above $150. Cronos, however, stood out as the day’s top performer, fueled by its unexpected weighting within the fund and the immediate interest it sparked among traders and investors.
Cronos’ sharp rally highlighted the market’s sensitivity to the launch of innovative products — especially when they involve regulated offerings in the U.S., where no multi-asset crypto ETFs have yet received authorization. The project is still awaiting formal SEC approval, but the filing alone has already generated considerable attention.
So far, neither Truth Social nor its partners have issued further statements, though Cronos’ price action suggests the market will closely follow every regulatory development tied to this ETF.
